The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; CBT Pharmaceuticals; Flatiron Health; Kadmon; Karyopharm Therapeutics; Monteris Medical; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)
 
David A. Reardon
Honoraria - Abbvie; Advantagene; Agenus; Bristol-Myers Squibb; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Agenus; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); midatech (Inst); Omniox; Tragara (Inst)
 
Ajay P Abad
No Relationships to Disclose
 
William T. Curry
No Relationships to Disclose
 
Eric T. Wong
Honoraria - Advanced Medical; Novocure; UpToDate
Research Funding - Five Prime Therapeutics; Novocure; Orbus; Plexxikon; Vascular Biogenics
 
Ahmed Belal
No Relationships to Disclose
 
Jingxin Qiu
Honoraria - Merck
Consulting or Advisory Role - Merck
Speakers' Bureau - Merck
 
Kathleen Mogensen
No Relationships to Disclose
 
Cathy Schilero
No Relationships to Disclose
 
Alan Hutson
No Relationships to Disclose
 
Danielle Casucci
No Relationships to Disclose
 
Laszlo Mechtler
No Relationships to Disclose
 
Erik J Uhlmann
No Relationships to Disclose
 
Michael J Ciesielski
Employment - MimiVax
Leadership - MimiVax
Stock and Other Ownership Interests - MimiVax
Research Funding - MimiVax (Inst)
Patents, Royalties, Other Intellectual Property - Patent holder, SurVaxM
Travel, Accommodations, Expenses - MimiVax
 
Robert Fenstermaker
Employment - Dent Neurologic Institute (I)
Stock and Other Ownership Interests - MimiVax
Patents, Royalties, Other Intellectual Property - I hold several patents for technology related to cancer vaccines, antibodies and related cellular therapies